Table 2 Comparison between patients with autoimmune gastritis (AIG) and those with atrophic gastritis due to H. pylori-infection in this study.

A1

AIG

51​

W

O-P

3 > ​

3.4​

1​

3rd​

No​

PCAB + MNZ + STFX were used for 7 d

A2

AIG

58​

W

O-2​

4​

Negative​

0​

Not applicable

Famotidine​

A3

AIG

65​

M​

O-P

3 > ​

29.1​

1​

2nd​

No​

A4

AIG

64​

W

O-P

3 > ​

9.1​

1​

3rd​

No​

PCAB + MNZ + STFX were used for 7 d

A5

AIG

69​

W

O-P

3 > ​

7.5​

1​

2nd​

No​

A6

AIG

80​

W

O-P

3 > ​

0​

0​

Not applicable

No​

A7

AIG

80​

W

O-P

3 > ​

4

1​

2nd

VPZ10mg

A8

AIG

71​

W

O-P

3 > ​

2.7​

1​

2nd​

No​

A9

AIG

69​

M​

O-P

7.2​

11.2​

1​

3rd​

No​

PCAB + high dose AM were used for 14 d

A10

AIG

74​

W

O-P

N/A​

18.9​

1​

2nd​

No​

A11

AIG

63​

W

O-P

3 > ​

0.8​

1​

2nd​

No​

A12

AIG

40​

W

O-P

7.5​

2.7​

1​

2nd​

No​

A13

AIG

67​

W

O-P

6.2​

2.6​

1​

2nd​

No​

A14

AIG

77​

W

O-3​

3 > ​

3.5​

1​

2nd​

No​

A15

AIG

67​

W

O-P

16.2​

4.6​

1​

3rd​

No​

PCAB + MNZ + STFX were used for 7 d

A16

AIG

56

M​

O-P

4.2

5.2

1​

3rd

No​

PCAB + MNZ + STFX were used for 7 d

A17

AIG

66

W

O-P

3 > 

1

1​

2nd

No​

A18

AIG

71

M​

O-P

3 > 

3.4

1​

2nd

No​

A19

AIG

73

W

O-P

5.5

3

1​

2nd

No​

A20

AIG

73

W

O-3​

3

67.9

1​

2nd

No​

B1

AtGI (TypeB)

52​

W

C-3

N/A​

0​

5​

1st​

No​

B2

AtGI (TypeB)

83​

M​

C-2

N/A​

0.9​

4​

2nd​

No​

B3

AtGI (TypeB)

60​

W

C-2

N/A​

0.1​

5​

3rd​

No​

PCAB + MNZ + STFX were used for 10 d

B4

AtGI (TypeB)

68​

M​

C-3

N/A​

0.6​

3​

1st​

No​

B5

AtGI (TypeB)

57​

M​

C-3

N/A​

0.1​

3​

1st​

No​

B6

AtGI (TypeB)

76​

W

O-1

N/A​

1.5​

2​

1st​

No​

B7

AtGI (TypeB)

72​

W

C-3

N/A​

0.8​

0​

Natural eradication​

No​

B8

AtGI (TypeB)

65​

W

C-3

N/A​

0.3​

14​

2nd​

No​

B9

AtGI (TypeB)

87​

M​

C-3

N/A​

0.1​

6​

1st​

No​

B10

AtGI (TypeB)

80​

M​

O-1

N/A​

1.7​

7​

1st​

No​

Intestinal metaplasia

B11

AtGI (TypeB)

77​

W

O-2

N/A​

0.2​

7​

1st​

No​

B12

AtGI (TypeB)

53​

W

C-3

3.6​

0​

5​

1st​

No​

B13

AtGI (TypeB)

65​

W

O-2

N/A​

0​

6​

2nd​

No​

Intestinal metaplasia

B14

AtGI (TypeB)

78​

W

O-3

N/A​

0.1​

9​

2nd​

No​

B15

AtGI (TypeB)

68

W

O-1

N/A​

0

5​

1st

No​

B16

AtGI (TypeB)

47

M

O-3​

24.7

1.9

1

2nd​

No​

B17

AtGI (TypeB)

72

W

O-3​

N/A​

0.8

3

1st

No​

B18

AtGI (TypeB)

63

W

C-2

N/A​

0.6

5

3rd​

No​

PCAB40 + MNZ1000 + STFX200 for 7d

B19

AtGI (TypeB)

54

M

O-1

3.3

N/A​

5

1st

No​

Gastric ulcer